Vitura Health (ASX:VIT) FCF Margin % : 10.93% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Vitura Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vitura Health's Free Cash Flow for the six months ended in Dec. 2023 was A$6.6 Mil. Vitura Health's Revenue for the six months ended in Dec. 2023 was A$60.0 Mil. Therefore, Vitura Health's FCF Margin % for the quarter that ended in Dec. 2023 was 10.93%.

As of today, Vitura Health's current FCF Yield % is 20.10%.

The historical rank and industry rank for Vitura Health's FCF Margin % or its related term are showing as below:

ASX:VIT' s FCF Margin % Range Over the Past 10 Years
Min: -4040.32 Med: -139.68 Max: 19.6
Current: 9

During the past 5 years, the highest FCF Margin % of Vitura Health was 19.60%. The lowest was -4040.32%. And the median was -139.68%.

ASX:VIT's FCF Margin % is ranked better than
75.66% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.55 vs ASX:VIT: 9.00

Vitura Health FCF Margin % Historical Data

The historical data trend for Vitura Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitura Health FCF Margin % Chart

Vitura Health Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

-4,040.32

-286.83

19.60

7.48

Vitura Health Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial				32.16	10.91	7.92	7.05	10.93

Competitive Comparison of Vitura Health's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Vitura Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vitura Health's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vitura Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vitura Health's FCF Margin % falls into.

Vitura Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vitura Health's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	8.78	/	117.344
	=	7.48 %

Vitura Health's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	6.554	/	59.974
	=	10.93 %

Vitura Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of Vitura Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitura Health (ASX:VIT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vitura Health Ltd (ASX:VIT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

299 Toorak Road, Suite 8, Level 3, South Yarra, VIC, AUS, 3141

Website

https://www.vitura.com.au

Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has three business segments namely, the Medical segment, which involves the sale of medicinal cannabis products; the Clinics segment, which involves the operation of medicinal cannabis clinics; and the Consumer segment, which involves the sale of consumer (non-medical) products in Australia and previously in Asia. The company generates the majority of its revenue from the Medical segment. Geographically the company generates the majority of its revenue from Australia.

Vitura Health (ASX:VIT) Headlines

No Headlines